Accepting new patients

Dr. Christopher Yasenchak, MD

Medical Oncology ·  Male · Age 47

Dr. Yasenchak

Willamette Valley Cancer Institute & Research Center

520 Country Club Pkwy Eugene, OR 97401

Make an Appointment

Show Phone Number


Dr. Christopher Yasenchak, MD is a medical oncology specialist in Eugene, OR and has been practicing for 16 years. He graduated from Pennsylvania State University College Of Medicine in 1999 and specializes in medical oncology and hematology.


Insurance Check

Search for your insurance provider

Dr. Yasenchak accepts

Accepted insurance can change. Please double-check when making an appointment.

(541) 683-5001

Dr. Yasenchak accepts the following insurance:

Aetna
Choice Plus POS II
Cigna
Cigna HMO
Cigna PPO
Great West Healthcare-Cigna PPO
Open Access
First Health (Coventry Health Care)
LifeWise
Medical Mutual of Ohio
MultiPlan
MultiPlan PPO
PHCS Network PPO
ODS Health Plan
PacificSource
Preferred PSN
Providence Health Plans
Personal Option EPO
Preferred PPO
UnitedHealthCare
Choice Plus POS
Options PPO
PacifiCare
PacifiCare HMO
United Healthcare

Background Check

No malpractice claims found for Oregon
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Yasenchak's experience treating your condition or procedure

Dr. Yasenchak's Top Procedures and Conditions

Treatment Frequency
Cancer
high
high

Treatment Frequency

Dr. Yasenchak treats Cancer more than 80% of his peers

Dr. Yasenchak treats this condition more than 80% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer
Breast Diseases
normal
normal

Treatment Frequency

Dr. Yasenchak treats Breast Diseases more than 82% of his peers

Dr. Yasenchak treats this condition more than 82% of his peers

Central Nervous System Lymphoma
normal
normal

Treatment Frequency

Dr. Yasenchak treats Central Nervous System Lymphoma more than 75% of his peers

Dr. Yasenchak treats this condition more than 75% of his peers

Dr. Yasenchak's conditions and procedures:

  • Acute Leukemia
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • All Lymphoma
  • Anal and Rectal Cancer
  • Anal Disorders
  • Anemia
  • Autoimmune Diseases
  • Basal Cell Carcinoma
  • Bladder Cancer
  • Bleeding Disorders
  • Blood Disorders
  • Bone Cancer
  • Bone Disorders
  • Bone Marrow Biopsy
  • Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brain Disorders
  • Breast Cancer
  • Breast Diseases
  • Cancer
  • Central Nervous System Lymphoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Coagulation Disorders (incl. Hemophilia)
  • Colorectal Cancer
  • Deep Vein Thrombosis (DVT)
  • Esophageal Cancer
  • Esophageal Diseases
  • Fallopian Tube Cancer
  • Gallbladder and Biliary Tract Cancer
  • Gallbladder Cancer
  • Gastrointestinal Diseases
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Hodgkin's Disease
  • Hypercoagulable State
  • Immune Thrombocytopenic Purpura (ITP)
  • Kidney Cancer
  • Leukocytosis
  • Liver Cancer
  • Lung Cancer
  • Lymphocytosis
  • Lymphoma, Large-Cell
  • Macroglobulinemia (incl. Waldenstrom's )
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Melanoma
  • Meningiomas
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Myeloproliferative Disorders
  • Neuroendocrine Tumors
  • Neutropenia
  • Nodular Lymphoma
  • Non-Hodgkin's Lymphoma
  • Oral Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pancytopenia
  • Plasmapheresis
  • Polycythemia Rubra Vera
  • Primary Central Nervous System Lymphoma
  • Primary Hypercoagulable State (incl. Factor V Leiden Disease)
  • Prostate Cancer
  • Pulmonary Disease
  • Purpura
  • Reticulosarcoma
  • Salivary Gland Cancer
  • Secondary Malignancies
  • Skin Cancer
  • Small Intestine Cancer
  • Soft Tissue Sarcoma
  • Squamous Cell Carcinoma
  • Stomach and Small Intestine Cancer
  • Stomach Diseases
  • Testicular Cancer
  • Thoracentesis
  • Thrombocytosis
  • Thrombosis
  • Thymomas
  • Tongue Cancer
  • Tonsil Cancer
  • Urinary Disorders
  • Uterine Cancer
  • Uterine Diseases
  • Vaginal Cancer
  • Vascular Disease
  • Venous Embolism and Thrombosis
  • von Willebrand Disease

About Me

Direct and communicative, Dr. Christopher Yasenchak approaches situations and conversations in a forthright manner. He believes in stating the facts and then providing all the options in clear and understandable ways. He takes a team approach to working with patients, ensuring every patient develops with him a personalized treatment plan through a shared decision-making process.

Specialties

  • Medical Oncology
  • Hematology

Board Certifications

  • Hematology
  • Medical Oncology

Education

2006
Mayo Clinic College Of Medicine
Fellowship Hospital
2003
Johns Hopkins University School Of Medicine
Fellowship Hospital
2002
Mayo Clinic Graduate School Of Medicine
Residency Hospital
1999
Pennsylvania State University College Of Medicine
Medical School
2006
2003
2002
1999

Awards

Dr. Yasenchak's Reviews

Likelihood to recommend Dr. Yasenchak

4.5

Based on 8 reviews

5 Stars
87.5%
(7)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
12.5%
(1)

Leave a review

How likely are you to recommend
Dr. Yasenchak?
(Select your rating)
Average Wait Time
  • 10 – 15 minutes
Dr. Yasenchak's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Christopher Yasenchak, MD
Reply
My wife was in Dr Yasenchak's care, suffering from multiple myeloma. Despite a crystal-clear directive to the contrary, he took advantage of her delirium to strong-arm her into accepting chemotherapy. He did not have the ethics or the decency to call her husband or family. When she came to her senses and informed him that she wanted to die, he petulantly tried to badger her into letting him "treat" her for up to seven more years.
Was this helpful?
thumbs up icon option
thumbs down icon option4
Thank you for taking the time to leave this...Read More
×Post a ResponseAre you Dr. Christopher Yasenchak, MD?
Reply
I met with Dr Yasenchak in July 2015 to obtain a second opinion on my Chemo treatment. I was very impressed not only with his knowledge and opinion but his bedside manner as well. I discussed His treatment suggestions with my doctor and made changes to my Chemo Med concentration and changed treatment from 3 to 4 weeks.
Was this helpful?
thumbs up icon option3
thumbs down icon option
We are happy to hear you had such a positive...Read More
×Post a ResponseAre you Dr. Christopher Yasenchak, MD?

Leave a review

How was your experience with Dr. Yasenchak?

Locations

Willamette Valley Cancer Institute & Research Center

1
  • Call
  • Fax
  • Hours
    • Mon: 7:30am - 6:30pm
    • Tue: 7:30am - 6:30pm
    • Wed: 7:30am - 6:30pm
    • Thu: 7:30am - 6:30pm
    • Fri: 7:30am - 6:00pm
    • Sat: closed
    • Sun: closed
  • Directions
2
  • Call
  • Fax
  • Hours
    • Mon: 8:00am - 5:00pm
    • Tue: 8:00am - 5:00pm
    • Wed: 8:00am - 5:00pm
    • Thu: 8:00am - 5:00pm
    • Fri: closed
    • Sat: closed
    • Sun: closed
  • Directions

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Yasenchak treats patients.

Learn more

Compare Providers

More providers who are similar to Dr. Yasenchak

Show All Oncologists